|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.159 HKD | +2.58% |
|
+1.92% | +41.96% |
| Feb. 23 | Aceso Life Science Group Limited Announces Resignation of Xu Haiying as Executive Director | CI |
| 2023 | Aceso Life Science's Loss Widens in Fiscal H1 | MT |
Aceso Life Science Group Limited reported earnings results for the full year ended March 31, 2023. For the full year, the company reported sales was HKD 312 million compared to HKD 315 million a year ago. Net loss was HKD 264 million compared to HKD 370 million a year ago.
Basic loss per share from continuing operations was HKD 0.0361 compared to HKD 0.0514 a year ago. Diluted loss per share from continuing operations was HKD 0.0361 compared to HKD 0.0555 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +41.96% | 150M | |
| +11.54% | 7.78B | |
| +12.00% | 4.47B | |
| -28.00% | 1.55B | |
| +9.61% | 872M | |
| +13.12% | 542M | |
| -21.40% | 510M | |
| -1.81% | 493M | |
| +12.09% | 312M | |
| -16.02% | 284M |
ACESO LIFE SCIENCE GROUP LIMITED 
